Batool, Fareeha
Stutz, Céline
Petit, Catherine
Benkirane-Jessel, Nadia
Delpy, Eric
Zal, Franck
Leize-Zal, Elisabeth
Huck, Olivier
Article History
Received: 31 May 2020
Accepted: 17 August 2020
First Online: 8 September 2020
Competing interests
: The authors declare that the research was conducted in the absence of any commercial or financial relationship that could be construed as a potential conflict of interest. Franck Zal is the cofounder and CEO/CSO of HEMARINA and possesses shares, with Elisabeth Leize-Zal, in the company. Eric Delpy is an employee of Hemarina but does not hold shares. The other authors declare no conflicts of interest.